Huons Global Co., Ltd. (KOSDAQ:084110)

South Korea · Delayed Price · Currency is KRW

23,150

+50 (0.22%)

Sep 9, 2026, 3:30 PM KST

Market Cap	282.61B -50.9%
Revenue (ttm)	846.78B +4.1%
Net Income	22.58B +39.0%
EPS	1,843.86 +38.4%
Shares Out	12.21M
PE Ratio	12.56
Forward PE	n/a
Dividend	880.00 (3.70%)
Ex-Dividend Date	Aug 28, 2026

Volume	25,494
Open	22,900
Previous Close	23,100
Day's Range	22,900 - 23,250
52-Week Range	20,100 - 76,700
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 1965

Employees 120

Stock Exchange KOSDAQ

Ticker Symbol 084110

Full Company Profile

Financial Performance

In 2025, Huons Global's revenue was 847.45 billion, an increase of 4.18% compared to the previous year's 813.46 billion. Earnings were 28.84 billion, an increase of 11.82%.

Financial Statements